Why Wulf Sleep Contains No Melatonin — And Why That Is the Right Call

By Jeff — Head Formulator, Mr Wulf Men

Jeff has spent over 20 years in clinical supplement formulation. He was part of the team behind ATP Science, a two-time BRW Fast 100 company, and leads all formulation development for Mr Wulf Men.

Let me be upfront about something before this article goes any further.

There are two reasons Wulf Sleep contains no melatonin. The first is a clinical argument I have held for years and will spend most of this article making. The second is that melatonin is a Schedule 4 prescription-only medicine in Australia under the Therapeutic Goods Administration, and no consumer supplement brand here can include it in a product regardless of their formulation philosophy.

I could write the whole article as though the clinical argument was the only reason and nobody would know the difference. But that is not how I operate, and you deserve the full picture.

So here is the full picture: the regulatory situation in Australia made the decision easier to live with. The clinical argument would have led me to the same place regardless. Both are true simultaneously, and I find a certain satisfaction in the fact that Australian regulators and I arrived at the same conclusion from different directions.

With that established — here is why melatonin is not the answer to your sleep problem, regardless of whether you can legally buy it.

What Melatonin Actually Does

Melatonin is a hormone produced by the pineal gland in response to darkness. Its primary function is signalling sleep onset — it tells your brain and body that night has arrived and sleep should begin. This is a real and well-documented mechanism. The hormone exists for a reason and plays a genuine role in circadian rhythm regulation.

The problem is not what melatonin does. The problem is what melatonin does not do — and what the consumer market has collectively decided it does based on decades of conflated marketing and wishful thinking.

Melatonin does not lower cortisol. It does not facilitate the brainwave transition from beta wave alertness to alpha wave relaxation. It does not trigger the core body temperature drop required for sleep onset. It does not sustain GABAergic inhibitory tone through the night. It does not support Stage 3 or Stage 4 slow wave sleep architecture — the deep phases where physical recovery, growth hormone synthesis, and immune function are concentrated.

Melatonin signals sleep onset. That is its job. Done.

For a man over 30 with elevated evening cortisol, a nervous system that refuses to exit operational mode, and five years of progressively deteriorating sleep architecture, melatonin is addressing the most superficial layer of a multi-layer problem. It is the equivalent of posting a "sleep now" sign on a door that is structurally unable to open.

The Dose Problem the Industry Ignores

Consumer melatonin products in Australia — where they are available via prescription or pharmacist-only channels for adults 55 and over — and internationally, where they are sold freely over the counter, commonly contain doses of 3mg to 10mg.

The research supporting melatonin for sleep onset — the indication it is actually approved for — was largely conducted at doses of 0.5mg to 1mg. The therapeutic window is narrow. The consumer market consistently operates at three to ten times the dose shown to be effective, largely because higher doses produce a more immediate subjective sedative feeling, which consumers interpret as the product working.

The TGA has approved melatonin specifically at 2mg prolonged-release for the short-term treatment of primary insomnia in adults aged 55 and over. Note the specificity there: 2mg, prolonged-release, short-term, adults 55 and over. The American gummy containing 5mg of immediate-release melatonin marketed to anyone with a pulse and a credit card is operating in a completely different clinical category — one for which the approval evidence does not exist.

At doses above the therapeutic range, melatonin can worsen sleep architecture rather than improve it. The knock-out feeling that high-dose melatonin produces is not restorative sleep. It is suppression. You may sleep through the first cycle and wake more groggily than if you had taken nothing, because the receptor dynamics at higher doses produce a different pharmacological picture than the research doses intended.

The Long-Term Dependency Risk Nobody Talks About

This is the concern I held before the regulatory question was even relevant to me.

Your pineal gland produces melatonin based on a feedback loop. When exogenous melatonin is consistently present, the production signal is blunted. Over time — and the evidence on this is not definitive but the mechanism is plausible enough to take seriously — chronic supplementation at consumer doses may reduce your own melatonin production capacity.

You are borrowing a hormone from an external source. The body's response to sustained external hormone supply is typically to reduce its own output. This is why testosterone replacement therapy suppresses endogenous testosterone production. It is why prolonged steroid use requires post-cycle therapy. The feedback mechanism is fundamental mammalian endocrinology.

For sleep, this means a risk of progressive dependency — not the acute dependency of benzodiazepines, but a gradual erosion of your own sleep onset capability that makes the supplement increasingly necessary over time. You started taking it because you couldn't sleep. You now cannot sleep without it. The supplement has not solved the problem. It has become the problem.

I did not want to build a product that created this dynamic. A sleep supplement should improve your sleep architecture to the point where the supplement becomes less necessary over time, not more.

What the TGA Actually Says About Melatonin in Australia

For Australian readers trying to understand the regulatory landscape:

In Australia, products containing melatonin are scheduled as either prescription medicines (Schedule 4) or pharmacist-only medicines (Schedule 3). The different schedule depends on specific criteria around safety, potential for misuse, and where it can be purchased.

In practical terms: melatonin over the counter in Australia is only available for adults aged 55 and over with short-term insomnia. For everyone else — the 35-year-old high-performer dealing with the wired-tired loop, the 42-year-old whose sleep has been deteriorating for three years — melatonin requires a prescription from a GP.

In September 2025, the Therapeutic Goods Administration issued a safety alert after laboratory testing found imported, unregistered melatonin products with doses that don't match their labels — in some cases exceeding 400%, in others containing little or no melatonin at all.

This is not a theoretical risk. Australians purchasing melatonin from overseas online stores are receiving products with dose inconsistencies of up to 400% in either direction — either far more than the label states or essentially none at all. This is the quality control gap that the TGA's scheduling framework exists to prevent and that offshore supplement marketing ignores entirely.

The regulatory framework exists for legitimate reasons. I happen to agree with the underlying clinical logic even if I might quibble with some of the scheduling specifics.

What We Use Instead — And Why It Is Better

The question a formulator has to answer when melatonin is off the table — clinically, commercially, and in our case regulatorily — is: what actually produces the sleep outcome melatonin was supposed to produce, more completely and without the dependency risk?

The answer is to target every mechanism that melatonin was never targeting in the first place.

The natural melatonin pathway, not the hormone itself. Wulf Sleep contains Tart Cherry at 1000mg — one of the only food-based sources of natural melatonin alongside tryptophan, the amino acid precursor to serotonin and melatonin. Rather than delivering the hormone exogenously, we are supplying the pathway support that allows your own production to function optimally. Your pineal gland continues doing its job. Your feedback loop remains intact. No dependency dynamic.

The cortisol problem melatonin ignores. Lactium® at 200mg — patented alpha-casozepine that binds to the GABA-A receptor and directly reduces evening cortisol. The most common reason melatonin fails for men over 30 is that elevated cortisol creates a physiological environment where sleep onset is suppressed regardless of what the melatonin signal says. Lactium® addresses the cortisol directly. No melatonin product does this.

The temperature drop melatonin doesn't trigger. Glycine at 3000mg facilitates the core body temperature reduction that sleep onset physically requires — the mechanism that makes the transition from wakefulness to sleep physiologically possible. Melatonin is a signal. Glycine is an enabler of the actual physical process.

The brainwave transition melatonin doesn't facilitate. PharmaGABA™ at 130mg — naturally fermented, EEG-confirmed — shifts the nervous system from beta wave dominance to alpha wave relaxation. L-theanine at 200mg synergises on the same transition. A brain that cannot exit operational mode will not respond to a melatonin signal regardless of dose. We address the neurology first.

The GABAergic foundation melatonin is built on but never strengthens. Magnesium Glycinate at 1650mg, Chamomile at 500mg standardised to 3.2% apigenin, Lemon Balm at 200mg inhibiting GABA transaminase, Taurine at 650mg as an inhibitory neuromodulator, Ziziphus Spinosa at 300mg for deep and sustained calm. The complete inhibitory architecture that sustains sleep through the full night rather than initiating it and stepping aside.

This is a more complete formulation than anything melatonin provides. It addresses every mechanism melatonin was supposed to address and every mechanism melatonin was never going to touch.

The Honest Summary on Melatonin

Melatonin is not without utility. As a circadian rhythm reset tool for jet lag, shift workers adjusting to new schedules, or short-term insomnia in older adults where endogenous production has declined — at 0.5mg to 1mg, under appropriate clinical guidance — it has a legitimate role.

As a nightly consumer sleep supplement at 5mg to 10mg for a 38-year-old man who cannot switch off at midnight because his cortisol is elevated, his GABA tone is inadequate, his magnesium is depleted, and his deep sleep architecture has been deteriorating for years — it is the wrong tool for the problem. It was always the wrong tool. The industry sold it as a universal solution because it was cheap, consumer-recognisable, and produced an immediately perceivable effect that felt like it was working.

The effect was not sleep. It was sedation. The difference matters.

Wulf Sleep was built for the actual problem. The absence of melatonin is not a gap in the formulation. It is the formulation being honest about what melatonin can and cannot do.

And yes — in Australia, we couldn't have included it anyway. Which, as I said, is a position I find myself entirely comfortable with.

The Regulatory Note for Those Ordering Melatonin Online

If you are considering importing melatonin products from overseas for personal use — a common workaround given the Australian scheduling — the TGA's September 2025 safety alert is worth reading in full. Laboratory testing of 18 imported products revealed dose inconsistencies in some cases exceeding 400% of the labelled amount. You are not necessarily receiving what the label states. You may be receiving significantly more, significantly less, or in some cases essentially none.

The quality control gap in offshore supplement products is real and the TGA's warning is based on laboratory evidence, not regulatory protectionism. If melatonin is something you want to explore under clinical guidance, the pathway in Australia is through your GP or a pharmacist for the Schedule 3 option if you are 55 or over.

For everyone else — Wulf Sleep is built for the problem melatonin was never equipped to solve.

A Note on the Performance Stack

The testosterone-sleep connection runs in both directions. Deep sleep is where testosterone is primarily synthesised. Low testosterone impairs sleep quality. If fixing the night in isolation feels incomplete — and for many men it is — The Performance Stack addresses both ends simultaneously. The same formulation philosophy applied to the daytime side of the loop.